Stock Code: 002433 stock abbreviation: Guangdong Taiantang Pharmaceutical Co.Ltd(002433) Announcement No.: 2022-015 Guangdong Taiantang Pharmaceutical Co.Ltd(002433)
Announcement on resolutions of the 33rd meeting of the 5th board of directors
The company and all members of the board of directors guarantee that the information disclosed is true, accurate and complete without false records, misleading statements or major omissions.
1、 Meetings held
The 33rd meeting of the 5th board of directors of Guangdong Taiantang Pharmaceutical Co.Ltd(002433) (hereinafter referred to as “the company”) was held in the conference room on the second floor of Qilin park on February 18, 2022 by combining on-site voting and communication voting. The meeting notice was sent by e-mail, fax, delivery and telephone on February 8, 2022. There are 8 directors who should attend the meeting and 8 directors who actually attend the meeting, which is in line with the quorum for convening the meeting of the board of directors. The meeting was presided over by Mr. Ke Shaobin, chairman of the board, and the supervisors and senior managers of the company attended the meeting as nonvoting delegates. The convening, convening and voting procedures of this meeting comply with the provisions of the company law, the articles of association, the rules of procedure of the board of directors and other relevant laws, administrative regulations, departmental rules and normative documents, and the meeting is legal and effective.
2、 Deliberations of the meeting
After careful deliberation and voting by open ballot, the directors present at the meeting passed the following matters: (I) the proposal on providing guarantee amount for wholly-owned subsidiaries was deliberated and adopted
Voting results: 8 in favor, 0 against and 0 abstention.
This proposal still needs to be submitted to the general meeting of shareholders for deliberation.
The Guangdong Taiantang Pharmaceutical Co.Ltd(002433) announcement on providing guarantee amount for wholly-owned subsidiaries and the independent opinions issued by independent directors were disclosed on the same day in China Securities News, securities times, Shanghai Securities News, securities daily and cninfo（ http://www.cn.info.com.cn. )。
(II) deliberated and passed the proposal on providing guarantee for the payment of kangaido
Voting results: 6 in favor, 0 against and 0 abstention.
Ms. Ke Shaofang and Mr. Ke Shaobin have been disqualified from voting.
This proposal still needs to be submitted to the general meeting of shareholders for deliberation.
The Guangdong Taiantang Pharmaceutical Co.Ltd(002433) announcement on providing guarantee for the payment of kangaido and the independent opinions issued by the independent directors were disclosed on the same day in China Securities News, securities times, Shanghai Securities News, securities daily and cninfo（ http://www.cn.info.com.cn. )。
3、 Documents for future reference
Resolution of the 33rd meeting of the 5th board of directors signed by the participating directors
It is hereby announced
Guangdong Taiantang Pharmaceutical Co.Ltd(002433) board of directors February 19, 2002
